SELLAS Life Sciences Group, Inc.SLSNASDAQ
Loading
Debt to Equity Over TimeCompressed
Percentile Rank21
3Y CAGR-58.3%
5Y CAGR-16.8%
Year-over-Year Change
Debt-to-equity ratio
3Y CAGR
-58.3%/yr
Annual compound
5Y CAGR
-16.8%/yr
Recent deceleration
Percentile
P21
Within normal range
vs 5Y Ago
0.4x
Contraction
Streak
1 yr
Consecutive declineCompressed
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 0.01 | -86.6% |
| 2024 | 0.11 | +193.1% |
| 2023 | -0.11 | -158.3% |
| 2022 | 0.19 | +390.6% |
| 2021 | 0.04 | +12.0% |
| 2020 | 0.04 | -0.5% |
| 2019 | 0.04 | - |
| 2018 | 0.00 | -100.0% |
| 2017 | 5.31 | +827.7% |
| 2016 | 0.57 | - |